Navigation Links
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Date:8/19/2007

Company on Target to File Supplemental New Drug Application in the Fourth

Quarter

FRAZER, Pa., Aug. 16 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced positive results from a 12-week, Phase 3 clinical trial of FENTORA(R) (fentanyl buccal tablet) [C-II] in patients with breakthrough pain associated with a broad range of chronic non-cancer pain conditions. The study achieved statistical significance on the primary endpoint. Results across the 12 weeks of treatment showed both statistically significant and clinically relevant outcomes for patients with breakthrough pain who were already receiving and who were tolerant to opioid therapy for their underlying persistent pain. FENTORA is approved only for the management of breakthrough pain in patients with cancer who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

"We are excited to complete our Phase 3 program with this third and final controlled study. These data show similar positive outcomes as those with FENTORA in treating breakthrough pain in opioid-tolerant patients with cancer, chronic neuropathic pain, and chronic low-back pain," said Dr. Lesley Russell, Executive Vice President, Worldwide Medical and Regulatory Operations. "We plan to submit these data to the Food and Drug Administration in the fourth quarter as part of our supplemental New Drug Application."

About the Study

The double-blind, placebo-controlled, variable dose Phase 3 trial included 148 patients. The primary endpoint was the Sum of Pain Intensity Differences from five to 60 minutes (SPID(60)) as assessed after 12 weeks of treatment. SPID(60) is a measure that assesses analgesic efficacy of a pain medication over the first 60 minutes after treatment. Patients treated with FENTORA showed a statistically significant improvement on the primary endpoint (p<0.0001) compared with placebo. FENTORA was general
'/>"/>

SOURCE Cephalon, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Presents Positive Results for Fentora in Breakthrough Pain Associated with Neuropathic Conditions
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Intercept Pharmaceuticals, Inc. ... biopharmaceutical company focused on the development and commercialization of ... such as primary biliary cirrhosis, today announced that ... Executive Officer, will present at the Deutsche Bank Securities ... on Wednesday, May 29, 2013 at 4:10 ...
(Date:5/23/2013)... , May 23, 2013 Isis Pharmaceuticals, Inc. (NASDAQ: ... announced that management will present a company overview at the ... on Thursday, May 30, 2013 at 8:40 a.m. ET in ... audio webcast of the presentation will be available on the ... www.isispharm.com .  A replay will be available on the Isis ...
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ( ... FDA, Health Canada and CE ( Europe ... Glasgow Science Centre in Scotland , ... the SynCardia temporary Total Artificial Heart powered ... $3 million Bodyworks Exhibition, one of the most advanced ...
Breaking Medicine Technology:Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3
... (NASDAQ: OCLR ), a tier-one provider of innovative ... for its second quarter of fiscal year 2012, which ended ... of fiscal 2012, Oclaro achieved revenue at the high end ... efforts from the recent Thailand flooding,” said Alain Couder, chairman ...
... J. Haimowitz, Executive Vice President, Group Director, Intelligence and Analytics, ... eMarketing University for Brand Managers, a symposium at the ePharma ... The symposium is a full-day course designed for those ... their marketing mix. Dr. Haimowitz will be presenting on the ...
Cached Medicine Technology:Oclaro Announces Second Quarter Fiscal Year 2012 Financial Results 2Oclaro Announces Second Quarter Fiscal Year 2012 Financial Results 3Oclaro Announces Second Quarter Fiscal Year 2012 Financial Results 4Oclaro Announces Second Quarter Fiscal Year 2012 Financial Results 5Oclaro Announces Second Quarter Fiscal Year 2012 Financial Results 6Oclaro Announces Second Quarter Fiscal Year 2012 Financial Results 7Oclaro Announces Second Quarter Fiscal Year 2012 Financial Results 8Oclaro Announces Second Quarter Fiscal Year 2012 Financial Results 9Oclaro Announces Second Quarter Fiscal Year 2012 Financial Results 10Oclaro Announces Second Quarter Fiscal Year 2012 Financial Results 11Ira Haimowitz, PhD, EVP, at The CementBloc, to Present on Best Practices in iPad Interactive Selling at 11th Annual ePharma Summit™ 2
(Date:5/23/2013)... Looking for tips on how to avoid ... of caring for your aging parent? Today the ... released the results of a survey of 335 geriatric care ... , Here are the top 5 tips identified by these ... survey respondents selecting each option): , 1.    Give each family member ...
(Date:5/23/2013)... As Stryker hip lawsuit claims associated ... Hip Stems continue to mount in courts throughout the country, ... connection between the type of corrosion that prompted the recall ... published on May 15th in the Journal of Bone and ... reported new-onset and increasing pain within months of undergoing ...
(Date:5/23/2013)... 23 May 2013.- CNIC researchers have discovered that the ... release of hematopoietic stem cells from the bone marrow ... in the journal Cell ., Neutrophils are leukocytes ... from bacteria and other disease organisms. To perform their ... into contact with microorganisms. However, release of these substances ...
(Date:5/23/2013)... To kick off barbecue season, fire up ... by cutting calories with simple tips from Retrofit weight ... calorie-overboard this summer. , “The powerful heat of the grill ... if you are not mindful of your selections, it can ... Registered Dietitian Amy Margulies. , Margulies advises clients to choose ...
(Date:5/23/2013)... May 23, 2013 A medical Internet ... Surge, LLC. Targeting members of the medical and healthcare ... attract new patients, the consulting service is focused on ... , The medical Internet marketing agency is providing the ... results online. As part of the consulting, the company ...
Breaking Medicine News(10 mins):Health News:New Survey of Aging Experts Gives Top 5 Tips for Avoiding Family Feud when Caring for Aging Parents 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 3Health News:Discarded immune cells induce the relocation of stem cells 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 3Health News:Healthcare Internet Marketing Consulting Services Launched by JD Media Surge 2
... modernize government efforts , , THURSDAY, April 9 (HealthDay News) ... incidence of many foodborne illnesses in the United States ... Thursday. , "Progress has plateaued," Dr. Robert Tauxe, deputy ... Diseases at the U.S. Centers for Disease Control and ...
... NPA-USP Chinese Raw Materials Testing Program Was Featured ... 9 Chondroitin from Shandong Zhongyuan Greentech Co., ... been tested for purity by the Natural Products ... The results of those tests are now available ...
... one of the largest hospital union elections in New ... good, secure jobs BOSTON , April 9 ... medical center in the Caritas Christi Health Care chain, ... Healthcare Workers East following a hospital-wide vote. The vote ...
... University Medical Center is testing a new procedure for ... relieve the pain of osteoarthritis. Rush is the ... III clinical trial. , The procedure, called the Cartilage ... healthy tissue that remains in the knee, breaking it ...
... Protecting Patients and Health Care Safety NetNAPERVILLE, Ill., April ... the state and national economic crisis, according to a ... survey found that hospitals, many of which were already ... facing new and significant financial challenges, with patients being ...
... Walk Launched to Expand Participation and Donations , NEW ... Parkinson,s disease community will unite in New York City,s ... to raise awareness and funds for Parkinson,s disease research. ... opportunity for this community to come together to celebrate ...
Cached Medicine News:Health News:Declines in Foodborne Illness Have Plateaued, Report Says 2Health News:Natural Products Association Announces Chondroitin Testing Results For Greentech 2Health News:Nearly 900 Workers at Caritas St. Elizabeth's Medical Center Make History With Vote to Join 1199SEIU 2Health News:Nearly 900 Workers at Caritas St. Elizabeth's Medical Center Make History With Vote to Join 1199SEIU 3Health News:Study assesses new surgical procedure for regenerating cartilage in damaged knee joints 2Health News:Illinois Hospitals Hit Hard By Recession 2Health News:Illinois Hospitals Hit Hard By Recession 3Health News:Parkinson's Disease Community Unites to Find a Cure at the 15th Annual Parkinson's Unity Walk 2Health News:Parkinson's Disease Community Unites to Find a Cure at the 15th Annual Parkinson's Unity Walk 3
... Battery Powered Orthopedic Systems., ,The PowerPro® ... to the Hall® Surgical line of powered ... the first and only software controlled battery ... is a full-function orthopedic power system specifically ...
... System is an evolutionary product for the ... initially designed specifically for use with the ... quickly becoming a new standard for use ... includes a unique method to deliver sutures ...
... to manufacture a diode pumped solid-state green ... their newest addition, the VITRA. This lightweight ... that many doctors face when traveling to ... than a shoe box, this rugged and ...
... Like all Gilson disposable pipette ... a sterilized version. Each Sterilized ... medical device-quality plastic to help ... is guaranteed by the red ...
Medicine Products: